CH484277A - Verfahren zur Vermehrung von Masernviren, welche zur Herstellung einer Vaccine gegen Masern geeignet sind - Google Patents

Verfahren zur Vermehrung von Masernviren, welche zur Herstellung einer Vaccine gegen Masern geeignet sind

Info

Publication number
CH484277A
CH484277A CH1232166A CH1232166A CH484277A CH 484277 A CH484277 A CH 484277A CH 1232166 A CH1232166 A CH 1232166A CH 1232166 A CH1232166 A CH 1232166A CH 484277 A CH484277 A CH 484277A
Authority
CH
Switzerland
Prior art keywords
measles
multiplication
production
vaccine against
viruses
Prior art date
Application number
CH1232166A
Other languages
German (de)
English (en)
Inventor
Enders-Ruckle Gisela
Hennessen Walter
Mauler Rudolf
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of CH484277A publication Critical patent/CH484277A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH1232166A 1965-08-28 1966-08-25 Verfahren zur Vermehrung von Masernviren, welche zur Herstellung einer Vaccine gegen Masern geeignet sind CH484277A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB83486A DE1247548B (de) 1965-08-28 1965-08-28 Verfahren zur Herstellung einer Masern-Vaccine

Publications (1)

Publication Number Publication Date
CH484277A true CH484277A (de) 1970-01-15

Family

ID=6981993

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1232166A CH484277A (de) 1965-08-28 1966-08-25 Verfahren zur Vermehrung von Masernviren, welche zur Herstellung einer Vaccine gegen Masern geeignet sind

Country Status (9)

Country Link
AT (1) AT281280B (enrdf_load_stackoverflow)
BE (1) BE686101A (enrdf_load_stackoverflow)
BR (1) BR6682416D0 (enrdf_load_stackoverflow)
CH (1) CH484277A (enrdf_load_stackoverflow)
DE (1) DE1247548B (enrdf_load_stackoverflow)
DK (2) DK119938B (enrdf_load_stackoverflow)
FR (2) FR1502631A (enrdf_load_stackoverflow)
GB (1) GB1161414A (enrdf_load_stackoverflow)
NL (1) NL6611851A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
CN104498446B (zh) * 2014-12-15 2017-03-15 北京科兴生物制品有限公司 一种在疫苗生产中灭活病毒的方法

Also Published As

Publication number Publication date
FR5666M (enrdf_load_stackoverflow) 1968-01-02
FR1502631A (fr) 1967-11-24
DK121811B (da) 1971-12-06
BE686101A (enrdf_load_stackoverflow) 1967-02-28
DE1247548B (de) 1967-08-17
AT281280B (de) 1970-05-11
NL6611851A (enrdf_load_stackoverflow) 1967-03-01
GB1161414A (en) 1969-08-13
DK119938B (da) 1971-03-15
BR6682416D0 (pt) 1973-12-04

Similar Documents

Publication Publication Date Title
CH484138A (de) Verfahren zur Herstellung von 1,2,3,4-Tetrahydro-9-amino-acridinen
AT271479B (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
CH547816A (de) Verfahren zur herstellung von aminothiophen-derivaten.
CH493519A (de) Verfahren zur Herstellung von 2,3-Pyridindiol
CH485694A (de) Verfahren zur Herstellung von 4,7a-Dimethyl-4-androstenen
CH488682A (de) Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
CH467861A (de) Verfahren zur Vermehrung von Staupeviren, welche zur Herstellung einer Vaccine zur Immunisierung von Musteliden gegen Staupe geeignet sind
CH484277A (de) Verfahren zur Vermehrung von Masernviren, welche zur Herstellung einer Vaccine gegen Masern geeignet sind
CH461499A (de) Verfahren zur Herstellung von 5H-Dibenzo-(b,f)-azepin
AT272295B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
CH458336A (de) Verfahren zur Herstellung von 3-Keto- 4,5-6,6-spirocyclopropylsteroiden
CH482714A (de) Verfahren zur Herstellung von substituierten 1,3,4-Oxathiazol-2-onen
AT272294B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
CH508667A (de) Verfahren zur Herstellung von 2-Bisdiestern von Phosphonomethylamino-1,3-dihydroxypropan
AT259771B (de) Verfahren zur Herstellung von 6,7-Benzomorphanen
CH471072A (de) Verfahren zur Herstellung von 3,4-Dihydroxy-phenyl-alkanolaminen
CH461480A (de) Verfahren zur Herstellung von 6a, 9a-Difluor-16-methylen-1,4-pregnadien-3,20-dion-11B,17a-diol
CH451195A (de) Verfahren zur Herstellung von 2-Chlor-4H-1,3,2-dioxaphosphorin-4-one
CH481057A (de) Verfahren zur Herstellung von 1,3-Diaminoadamantanen
CH487170A (de) Verfahren zur Herstellung von 1,4-Diazacycloheptanen
CH468347A (de) Verfahren zur Herstellung von a,w-Diaminoalkancarbonsäuren
CH480354A (de) Verfahren zur Herstellung von substituierten 1,3-Oxathiol-2-onen
CH464233A (de) Verfahren zur Herstellung konzentrierter, wässriger Emulsionen
CH483415A (de) Verfahren zur Herstellung von 3-Alkoxy-6-cyan-3,5-pregnadienen
CH491930A (de) Verfahren zur Herstellung von 2,4,6-Trifluor-5-chlorpyrimidin

Legal Events

Date Code Title Description
PL Patent ceased